Therapeutic Advances in Urology

SAGE Publishing

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Therapeutic Advances in Urology is an open-access journal published by SAGE Publishing in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,650 USD. Declared review time at DOAJ: 10 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
SAGE Publishing
ISSN
1756-2872 · 1756-2880
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
2,650 USD
Articles in DOAJ
712
Declared review time
10 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2019-05-03
Indexing
DOAJ
APC
2,650 USD
Declared review time (DOAJ)
10 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

712

Most recent article

last month

Average review time (journal-declared via DOAJ)

10weeks

Works in OpenAlex

701

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

56

i10-index

374

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2024-04-04
Added to DOAJ
2019-05-03
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSLOCKSSPMCPorticoScholars Portal
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
96%
ORCID iDs in current deposits
96%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
Urology
Source type
journal
NLM unique ID (PubMed)
101487328
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology

LCC codes

RC870-923

Subject areas

  • Urinary Bladder and Prostate Research
  • Urinary Bladder and Prostate Research
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Diagnosis and Treatment
  • Bladder and Urothelial Cancer Treatments
  • Pelvic floor disorders treatments
  • Pelvic floor disorders treatments
  • Bladder and Urothelial Cancer Treatments
Show all subjects (50)
  • Prostate Cancer Treatment and Research
  • Urinary Tract Infections Management
  • Prostate Cancer Treatment and Research
  • Urinary Tract Infections Management
  • Kidney Stones and Urolithiasis Treatments
  • Kidney Stones and Urolithiasis Treatments
  • Sexual function and dysfunction studies
  • Sexual function and dysfunction studies
  • Urological Disorders and Treatments
  • Urological Disorders and Treatments
  • Renal cell carcinoma treatment
  • Renal cell carcinoma treatment
  • Pediatric Urology and Nephrology Studies
  • Ureteral procedures and complications
  • Pediatric Urology and Nephrology Studies
  • Ureteral procedures and complications
  • Urinary and Genital Oncology Studies
  • Urinary and Genital Oncology Studies
  • Hormonal and reproductive studies
  • Hormonal and reproductive studies
  • Genital Health and Disease
  • Genital Health and Disease
  • Urologic and reproductive health conditions
  • Urologic and reproductive health conditions
  • Renal and related cancers
  • Renal and related cancers
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Radiopharmaceutical Chemistry and Applications
  • Radiopharmaceutical Chemistry and Applications
  • Cancer Genomics and Diagnostics
  • Testicular diseases and treatments
  • Testicular diseases and treatments
  • Renal and Vascular Pathologies
  • Minimally Invasive Surgical Techniques
  • Renal and Vascular Pathologies
  • Sperm and Testicular Function
  • Sperm and Testicular Function
  • Minimally Invasive Surgical Techniques
  • MRI in cancer diagnosis
  • MRI in cancer diagnosis

Keywords (DOAJ)

  • urology
  • clinical urology
  • pharmacology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: